Canntab Therapeutics Limited
CTABF
$0.00
$0.000.00%
OTC PK
02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -98.95% | -84.22% | -85.68% | -55.76% | 4.91% |
Total Receivables | -85.00% | -67.76% | 30.65% | -3.44% | -79.16% |
Inventory | -82.69% | -66.23% | -67.38% | -72.86% | 45.89% |
Prepaid Expenses | -- | -61.09% | -3.25% | -25.82% | -18.12% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -90.53% | -69.39% | -65.95% | -60.23% | -10.33% |
|
|||||
Total Current Assets | -90.53% | -69.39% | -65.95% | -60.23% | -10.33% |
Net Property, Plant & Equipment | -81.04% | -66.57% | -62.36% | -59.55% | -37.58% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -15.72% | -7.70% | -8.24% | 0.29% | 5.07% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -83.21% | -63.66% | -61.27% | -57.21% | -20.65% |
|
|||||
Total Accounts Payable | -23.24% | 70.17% | -87.61% | -84.88% | -74.04% |
Total Accrued Expenses | 32.94% | 10.78% | 56.18% | 110.82% | 114.30% |
Short-term Debt | -6.96% | -5.54% | -3.37% | -4.63% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 24.35% | 698.15% | 687.79% | 653.94% | 453.67% |
Total Finance Division Other Current Liabilities | -98.75% | -- | -- | 81.55% | -- |
Total Other Current Liabilities | -98.75% | -- | -- | 81.55% | -- |
Total Current Liabilities | 4.95% | 141.59% | 42.40% | 46.60% | 80.65% |
|
|||||
Total Current Liabilities | 4.95% | 141.59% | 42.40% | 46.60% | 80.65% |
Long-Term Debt | -- | -83.58% | -85.86% | -87.56% | -33.79% |
Short-term Debt | -6.96% | -5.54% | -3.37% | -4.63% | -- |
Capital Leases | -- | -43.42% | -43.80% | -45.67% | -44.17% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -77.37% | -92.51% | -75.98% | -- |
Total Liabilities | -31.52% | -3.48% | -22.06% | -26.22% | 28.17% |
|
|||||
Common Stock & APIC | -6.07% | -1.45% | 2.33% | 8.12% | 16.14% |
Retained Earnings | -13.61% | -16.00% | -21.91% | -22.50% | -42.82% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -290.54% | -273.78% | -137.02% | -113.09% | -68.61% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -290.54% | -273.78% | -137.02% | -113.09% | -68.61% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -290.54% | -273.78% | -137.02% | -113.09% | -68.61% |
|